Highlights
TSX: ZYME       Zymeworks Inc
Last Price Today's Change   Day's Range   Trading Volume
33.10   +0.53 (1.63%)  32.77 - 33.53  5,350

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:14.66 - 33.53
52 Weeks Price Volatility (%):
97.72%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Zymeworks Inc is a clinical-stage biopharmaceutical company. It is dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer. The company's product candidate, ZW25, is a bispecific (dual-targeting) antibody being evaluated in an adaptive Phase 1 clinical trial, targeting two distinct domains of the human epidermal growth factor receptor 2, or HER2. Its design enables ZW25 to address patient populations with all levels of HER2 expression, including those with low to intermediate HER2-expressing tumors, who are otherwise limited to chemotherapy or hormone therapy.

  Be the first to like this.
 


 

890  748  1234  1712 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CVE 12.33+0.88 
 ECA 5.35+0.16 
 MFC 25.45+0.35 
 CNQ 38.91+2.00 
 HOD 3.975-0.095 
 CPG 4.80+0.19 
 BTE 1.50+0.05 
 SU 42.35+1.53 
 MRS 0.105+0.02 
 ARX 7.48+0.48 
Partners & Brokers